KYMR 44.05 (+2.82%)
US5015751044BiotechnologyBiotechnology

Kymera Therapeutics (KYMR) Stock Highlights

44.05 | +2.82%
2024-11-21 02:19:05
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the bodys innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymeras Pegasus targeted protein degradation platform harnesses the bodys natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Statistics

Range Today
42.1 44.1
Volume Today 385.03K
Range 1 Year
18.89 53.27
Volume 1 Year 157.47M
Range 3 Year
9.6 66.45
Volume 3 Year 450.71M
Range 10 Year
9.6 91.92
Volume 10 Year 553.51M

Highlights

Market Capitalization 3.3B (mid)
Floating Shares 43.99M
Current Price 44.05
Price To Earnings -20.88
Price To Revenue 32.41
Price To Book 3.69
Earnings Per Share -2.39
Payout Ratio 0%

Performance

Latest +2.82%
1 Month -4.72%
3 Months -6.24%
6 Months +25.79%
1 Year +126.48%
3 Years -30.12%
5 Years +25.82%
10 Years +25.82%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.